{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:18:14Z","timestamp":1784809094674,"version":"3.55.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The understanding of the association between KRAS<\/jats:italic> sequence variation status and clinical outcomes in colorectal cancer (CRC) has evolved over time.<\/jats:p><\/jats:sec>Objective<\/jats:title>To characterize the association of age at onset, tumor sidedness, and KRAS<\/jats:italic> sequence variation with survival among patients diagnosed with CRC.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study used data extracted from the Surveillance, Epidemiology, and End Results database. Patients diagnosed with adenocarcinoma of the colon or rectum from 2010 through 2015 were included and were classified as having young-onset (YO) cancer if diagnosed between ages 20 to 49 years and late-onset (LO) cancer if diagnosed at age 50 years or older. Data were analyzed from April 2021 through August 2023.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>CRC cause-specific survival (CSS) was summarized using Fine and Gray cumulative incidence and Kaplan-Meier curves. Estimation of subdistribution hazard ratios (sHRs) for the association of KRAS<\/jats:italic> status, age at onset, and tumor location with CRC CSS was conducted using the Fine and Gray competing risk model. Cox proportional hazards regression was used to estimate and compare HRs.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 21\u202f661 patients with KRAS<\/jats:italic> sequence variation status (mean [SD] age at diagnosis, 62.50 [13.78] years; 9784 females [45.2%]), 3842 patients had YO CRC, including 1546 patients with KRAS<\/jats:italic> variants, and 17\u202f819 patients had LO CRC, including 7311 patients with KRAS<\/jats:italic> variants. There was a significant difference in median CSS time between patients with variant vs wild-type KRAS<\/jats:italic> (YO: 3.0 years [95% CI, 2.8-3.3 years] vs 3.5 years [95% CI, 3.3-3.9 years]; P<\/jats:italic>\u2009=\u2009.02; LO: 2.5 years [95% CI, 2.4-2.7 years] vs 3.4 years [95% CI, 3.3-3.6 years]; P<\/jats:italic>\u2009&amp;lt;\u2009.001). Tumors with variant compared with wild-type KRAS<\/jats:italic> were associated with higher risk of CRC-related death (YO: sHR, 1.09 [95% CI, 1.01-1.18]; P<\/jats:italic>\u2009=\u2009.03; LO: sHR, 1.06 [95% CI, 1.02-1.09]; P<\/jats:italic>\u2009=\u2009.002). Among patients with YO cancer, mortality hazards increased by location, from right (sHR, 1.02 [95% CI, 0.88-1.17) to left (sHR, 1.15 [95% CI, 1.02-1.29) and rectum (sHR, 1.16 [95% CI, 0.99-1.36), but no trend by tumor location was seen for LO cancer.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study of patients diagnosed with CRC, KRAS<\/jats:italic> sequence variation was associated with increased mortality among patients with YO and LO tumors. In YO cancer, variant KRAS\u2013<\/jats:italic>associated mortality risk was higher in distal tumors than proximal tumors.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.45801","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:31:46Z","timestamp":1701361906000},"page":"e2345801","source":"Crossref","is-referenced-by-count":17,"title":["KRAS<\/i> Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset Colorectal Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Mayada A.","family":"Aljehani","sequence":"first","affiliation":[{"name":"Ellison Institute of Technology, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bien","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry S. H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Ellison Institute of Technology, Los Angeles, California"},{"name":"Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles"},{"name":"Department of Chemical Engineering and Material Sciences, Viterbi School of Engineering, University of Southern California, Los Angeles"},{"name":"Department of Quantitative and Computational Biology, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"George A.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, California"},{"name":"Division of Oncology, Department of Medicine, VA Palo Alto Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"1","key":"zoi231331r1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.v73.1","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi231331r2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.clinre.2018.09.003","article-title":"Incidence and characteristics of young-onset colorectal cancer in the United States: an analysis of SEER data collected from 1988 to 2013.","volume":"43","author":"Wang","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"16","key":"zoi231331r3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMra2200869","article-title":"Increasing incidence of early-onset colorectal cancer.","volume":"386","author":"Sinicrope","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi231331r4","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/cncr.31994","article-title":"Clinical and molecular characterization of early-onset colorectal cancer.","volume":"125","author":"Willauer","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"zoi231331r6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.mayocp.2013.09.006","article-title":"The increasing incidence of young-onset colorectal cancer: a call to action.","volume":"89","author":"Ahnen","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"zoi231331r7","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-19-0899","article-title":"Comprehensive genomic landscapes in early and later onset colorectal cancer.","volume":"25","author":"Lieu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"zoi231331r8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.humpath.2016.06.010","article-title":"High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.","volume":"56","author":"Watson","year":"2016","journal-title":"Hum Pathol"},{"key":"zoi231331r9","article-title":"A systematic review and meta-analysis on the prevalence of KRAS gene mutation in samples of colorectal cancer.","volume":"7","author":"Sadough","year":"2020","journal-title":"World Cancer Research Journal"},{"issue":"8","key":"zoi231331r10","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.","volume":"66","author":"Li\u00e8vre","year":"2006","journal-title":"Cancer Res"},{"issue":"9","key":"zoi231331r11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/90.9.675","article-title":"Kirsten ras mutations in patients with colorectal cancer: the multicenter \u201cRASCAL\u201d study.","volume":"90","author":"Andreyev","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi231331r12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1054\/bjoc.2001.1964","article-title":"Kirsten ras mutations in patients with colorectal cancer: the \u2018RASCAL II\u2019 study.","volume":"85","author":"Andreyev","year":"2001","journal-title":"Br J Cancer"},{"issue":"23","key":"zoi231331r13","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-09-1570","article-title":"KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.","volume":"15","author":"Ogino","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"zoi231331r14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.","volume":"28","author":"Roth","year":"2010","journal-title":"J Clin Oncol"},{"issue":"17","key":"zoi231331r15","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1158\/1078-0432.CCR-11-3210","article-title":"Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.","volume":"18","author":"Imamura","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"12","key":"zoi231331r16","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1093\/annonc\/mdu464","article-title":"Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.","volume":"25","author":"Blons","year":"2014","journal-title":"Ann Oncol"},{"issue":"11","key":"zoi231331r17","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1158\/1078-0432.CCR-13-3140","article-title":"KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).","volume":"20","author":"Yoon","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"9","key":"zoi231331r18","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO Colorectal Cancer Study Group.","volume":"27","author":"Modest","year":"2016","journal-title":"Ann Oncol"},{"issue":"5","key":"zoi231331r19","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw272","article-title":"Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer.","volume":"109","author":"Taieb","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi231331r20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju106","article-title":"Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG\/Alliance N0147.","volume":"106","author":"Gonsalves","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"zoi231331r21","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.6004\/jnccn.2017.7011","article-title":"KRAS testing, tumor location, and survival in patients with stage IV colorectal cancer: SEER, 2010\u20132013.","volume":"15","author":"Charlton","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"zoi231331r25","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"446","key":"zoi231331r26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"zoi231331r27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1158\/1078-0432.CCR-17-2484","article-title":"Classifying Colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes.","volume":"24","author":"Loree","year":"2018","journal-title":"Clin Cancer Res"},{"key":"zoi231331r28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2017.07.016","article-title":"Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes.","volume":"84","author":"Stintzing","year":"2017","journal-title":"Eur J Cancer"},{"key":"zoi231331r23","volume-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2000","edition":"3rd ed"},{"key":"zoi231331r5","unstructured":"American Cancer Society. American Cancer Society guideline for colorectal cancer screening. Accessed April 15, 2021. https:\/\/www.cancer.org\/cancer\/types\/colon-rectal-cancer\/detection-diagnosis-staging\/acs-recommendations.html"},{"key":"zoi231331r22","unstructured":"Surveillance, Epidemiology, and End Results Program. SEER is an authoritative source for cancer statistics in the United States. National Cancer Institute. Accessed August 13, 2021. https:\/\/seer.cancer.gov\/"},{"key":"zoi231331r24","unstructured":"Surveillance, Epidemiology, and End Results Program. Race and Hispanic ethnicity changes. National Cancer Institute. Accessed October 1, 2023. https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/race_ethnicity\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2812384\/aljehani_2023_oi_231331_1700251865.8972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T16:31:54Z","timestamp":1701361914000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2812384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.45801","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}